NORLUTATE

Pre-Launch

norethindrone acetate

Pfizer

NDAORALTABLET

Lifecycle

Pre-Launch

Clinical Trials

Clinical Trials (5)

NCT03271489Phase 3Completed

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Started Sep 2017

478 enrolled

Heavy Menstrual BleedingUterine Fibroids

NCT02832180Phase 1Completed

The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects

Started May 2016

25 enrolled

Arthritis

NCT02691494Phase 3Completed

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)

Started Feb 2016

378 enrolled

Uterine FibroidsHeavy Menstrual Bleeding

NCT02654054Phase 3Completed

Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Started Dec 2015

413 enrolled

Uterine FibroidsHeavy Menstrual Bleeding

NCT01157182Phase 1Completed

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

Started Feb 2007

36 enrolled

Healthy

Company